Publications dans lesquelles il/elle collabore avec Óscar María Beloqui Ruiz (13)

2023

  1. Association of Intima-Media Thickness Measured at the Common Carotid Artery With Incident Carotid Plaque: Individual Participant Data Meta-Analysis of 20 Prospective Studies

    Journal of the American Heart Association, Vol. 12, Núm. 12, pp. e027657

2020

  1. Does chronic kidney disease facilitate malignant myocardial fibrosis in heart failure with preserved ejection fraction of hypertensive origin?

    Journal of Clinical Medicine, Vol. 9, Núm. 2

  2. Unravelling gender-specific factors that link obesity to albuminuria

    European Journal of Clinical Investigation, Vol. 50, Núm. 11

2019

  1. Comparison of correlations of equation-derived body fat percentage and body mass index with carotid intima-media thickness

    Acta Diabetologica, Vol. 56, Núm. 3, pp. 373-375

2018

  1. Correction: Predictive value for cardiovascular events of common carotid intima media thickness and its rate of change in individuals at high cardiovascular risk - Results from the PROG-IMT collaboration (PLoS One (2018) 13:4 (e0191172) DOI: 10.1371/journal.pone.0191172)

    PLoS ONE

  2. Predictive value for cardiovascular events of common carotid intima media thickness and its rate of change in individuals at high cardiovascular risk – Results from the PROG-IMT collaboration

    PLoS ONE, Vol. 13, Núm. 4

2017

  1. Automatic identification of variables in epidemiological datasets using logic regression

    BMC Medical Informatics and Decision Making, Vol. 17, Núm. 1

  2. Increased phagocytic NADPH oxidase activity associates with coronary artery calcification in asymptomatic men

    Free Radical Research, Vol. 51, Núm. 4, pp. 389-396

2014

  1. A role for cardiotrophin-1?

    Hypertension, Vol. 63, Núm. 3, pp. 468-474

2011

  1. Relación entre las fases precoces de la enfermedad renal y el síndrome metabólico

    Revista Espanola de Cardiologia, Vol. 64, Núm. 5, pp. 373-378

  2. ¿el síndrome metabólico en España necesita más estudios descriptivos o más evidencia de su implicación en prevención secundaria? Respuesta

    Revista Espanola de Cardiologia

2010

  1. Is leptin involved in phagocytic NADPH oxidase overactivity in obesity? Potential clinical implications

    Journal of Hypertension, Vol. 28, Núm. 9, pp. 1944-1950

2009

  1. Insulin resistance determines phagocytic nicotinamide adenine dinucleotide phosphate oxidase overactivation in metabolic syndrome patients

    Journal of Hypertension, Vol. 27, Núm. 7, pp. 1420-1430